Abstract:Aims: The objective of this study was to examine the effect of hyperhomocysteinemia (HHcy)─elevated plasma Hcy level on endothelial function in resistant arteries of type 2 diabetic db/db mice. Methods and Results: Moderate HHcy (plasma tHcy=54.31±5.4 µmol/L) was developed in diabetic db/db mice fed with a high methionine diet (HM, 2% methionine) for 8 weeks starting from age of 8 weeks, whereas non‐diabetic db/+ mice developed mild HHcy (plasma tHcy=34.21±4.15 µmol/L). HHcy increased blood glucose levels from 474±29 mg/dl to 630±83 mg/dl in diabetic mice (p<0.05), whereas HHcy did not affect blood glucose levels in non‐diabetic mice. Endothelium‐dependent vascular relaxation to acetylcholine (Ach) was significantly impaired in the small mesenteric artery (SMA) of diabetic mice. Mild HHcy did not impair endothelium‐dependent vascular relaxation response to Ach in non‐diabetic mice. Moderate HHcy aggravated the impairment of vascular relaxation response to Ach in diabetic mice both in the presence or absence of eNOS inhibitor L‐NG‐nitroarginine methyl ester (L‐NAME). HHcy‐induced impairment of relaxation response to Ach in diabetic mice was diminished in the presence of L‐NAME plus intermediate‐conductance calcium‐activated potassium channel (IKCa) inhibitor tram‐34 and small conductance KCa (SKCa) blocker apamin. Our results suggest that impairment of endothelium‐derived hyperpolarizing factor (EDHF) via inactivation of IKCa and SKCa plays a critical role in HHcy‐aggravated endothelial dysfunction in the resistant artery of diabetic mice. Moreover, 40Gap27 and 43Gap26 significantly improved vascular relaxation response to Ach in mice with moderate HHcy and diabetes. Finally, HHcy significantly impaired endothelium‐independent vascular relaxation to sodium nitroprusside in diabetic mice. Conclusions: These findings demonstrate that HHcy‐induced impairment of EDHF may be resulted from inactivation of IKCa/SKCa and suppression of connexin 40 and connexin 43. Grant Funding Source : NIH

Homocysteine impaired endothelial function via compromised VEGF/Akt/eNOS signaling (Revised 1)

Homocysteine Impaired Endothelial Function Through Compromised Vascular Endothelial Growth Factor/Akt/Endothelial Nitric Oxide Synthase Signalling

Effects of Homocysteine on the Expression of Matrix Metalloproteinase-2 in Rat Vascular Smooth Muscle Cells

Interference in mevalonate pathway ameliorates homocysteine-induced endothelium-dysfunction.

Reduced Number and Activity of Circulating Endothelial Progenitor Cells from Patients with Hyperhomocysteinemia.

Homocysteine Impairs Coronary Artery Endothelial Function by Uncoupling Endothelial Nitric Oxide Synthase in Patients with Hyperhomocysteinemia

Homocysteine Reduces Protein S-Nitrosylation in Endothelium

Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.

Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation

Homocysteine Causes Endothelial Dysfunction via Inflammatory Factor-Mediated Activation of Epithelial Sodium Channel (ENaC)

Homocysteine Induces 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Vascular Endothelial Cells

Homocysteine Causes Vascular Endothelial Dysfunction by Disrupting Endoplasmic Reticulum Redox Homeostasis.

Homocysteine attenuates hemodynamic responses to nitric oxide in vivo.

Homocysteine-impaired Angiogenesis is Associated with VEGF VEGFR Inhibition

Homocysteine Induces Apoptosis of Human Umbilical Vein Endothelial Cells via Mitochondrial Dysfunction and Endoplasmic Reticulum Stress

Hyperhomocysteinemia aggravates endothelial dysfunction via EDHF impairment in resistant arteries of db/db mice (1051.13)

Homocysteine Up-Regulates Endothelin Type A Receptor in Vascular Smooth Muscle Cells Through Sirt1/ERK1/2 Signaling Pathway.

Hypercysteinemia promotes atherosclerosis by reducing protein S-nitrosylation.

Effects of Homocysteine on the Cytoskeleton-Actins and Function of Vascular Endothelial Cells

Moderate Elevation of Homocysteine Induces Endothelial Dysfunction through Adaptive UPR Activation and Metabolic Rewiring

Mechanism of homocysteine-mediated endothelial injury and its consequences for atherosclerosis